AACR Journal Highlights Industry and Regulatory Perspectives on Improving Diversity in Clinical Trials
Article provides timely information following new law that will require trial sponsors to submit Diversity Action Plans to FDA...
Article provides timely information following new law that will require trial sponsors to submit Diversity Action Plans to FDA...
PHILADELPHIA – First-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic...
Bertagnolli would be the second woman to head the NIH PHILADELPHIA – The American Association for Cancer Research (AACR)...
Researchers applied single-nucleus RNA sequencing and spatial transcriptomics to identify potential therapeutic targets in brain metastases ORLANDO, Fla. –...
ORLANDO, Fla. – A combination of the PARP inhibitor olaparib (Lynparza) and the investigational ATR inhibitor ceralasertib showed clinical...
ORLANDO, Fla. – An investigational deep learning model requiring one histopathologic slide accurately predicted the risk of distant recurrence...
ORLANDO, Fla. – Among individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for...
Philip D. Greenberg, MD, FAACR, Inaugurated as President PHILADELPHIA – The members of the American Association for Cancer Research...
REGN5459 had decreased binding affinity to T cells, resulting in an encouraging side effect profile and efficacy ORLANDO, Fla....
Most people are also not aware that HPV can cause anal, oral, and penile cancers ORLANDO, Fla. – Americans...